Home Cart Sign in  
Chemical Structure| 289499-45-2 Chemical Structure| 289499-45-2

Structure of Canertinib 2HCl
CAS No.: 289499-45-2

Chemical Structure| 289499-45-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

Synonyms: CI-1033 dihydrochloride; PD-183805 dihydrochloride; PD 183805

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Canertinib 2HCl

CAS No. :289499-45-2
Formula : C24H27Cl3FN5O3
M.W : 558.86
SMILES Code : C=CC(NC1=C(C=C2C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)=C1)OCCCN4CCOCC4)=O.[H]Cl.[H]Cl
Synonyms :
CI-1033 dihydrochloride; PD-183805 dihydrochloride; PD 183805
InChI Key :JZZFDCXSFTVOJY-UHFFFAOYSA-N
Pubchem ID :156413

Safety of Canertinib 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Canertinib 2HCl

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

    EGFR, IC50:7.4 nM

  • HER2/ErbB2

    ErbB2, IC50:9 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00051051 Breast Neoplasms PHASE2 COMPLETED 2025-05-05 Pfizer Investigational Site, M... More >>ontgomery, Alabama, 36106, United States|Pfizer Investigational Site, Arroyo Grande, California, 93420, United States|Pfizer Investigational Site, Montebello, California, 90640, United States|Pfizer Investigational Site, San Francisco, California, 94115, United States|Pfizer Investigational Site, Aurora, Colorado, 80010, United States|Pfizer Investigational Site, Aventura, Florida, 33180, United States|Pfizer Investigational Site, Miami Beach, Florida, 33140, United States|Pfizer Investigational Site, Plantation, Florida, 33324, United States|Pfizer Investigational Site, Chicago, Illinois, 60637-1470, United States|Pfizer Investigational Site, Maywood, Illinois, 60153, United States|Pfizer Investigational Site, Kansas City, Kansas, 66112, United States|Pfizer Investigational Site, Lenexa, Kansas, 66214, United States|Pfizer Investigational Site, Overland Park, Kansas, 66210, United States|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48109-0922, United States|Pfizer Investigational Site, Brownstown, Michigan, 48183, United States|Pfizer Investigational Site, Dearborn, Michigan, 48126, United States|Pfizer Investigational Site, Detroit, Michigan, 48202, United States|Pfizer Investigational Site, West Bloomfield, Michigan, 48322, United States|Pfizer Investigational Site, Kansas City, Missouri, 64111, United States|Pfizer Investigational Site, Kansas City, Missouri, 64131, United States|Pfizer Investigational Site, Kansas City, Missouri, 64154, United States|Pfizer Investigational Site, Lee's Summit, Missouri, 64064, United States|Pfizer Investigational Site, Bronx, New York, 10461, United States|Pfizer Investigational Site, Bronx, New York, 10467, United States|Pfizer Investigational Site, Cleveland, Ohio, 44106, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Pfizer Investigational Site, Gallatin, Tennessee, 37066, United States|Pfizer Investigational Site, Hermitage, Tennessee, 37076, United States|Pfizer Investigational Site, Lebanon, Tennessee, 37087, United States|Pfizer Investigational Site, Murfreesboro, Tennessee, 37130, United States|Pfizer Investigational Site, Nashville, Tennessee, 37203, United States|Pfizer Investigational Site, Nashville, Tennessee, 37205, United States|Pfizer Investigational Site, Nashville, Tennessee, 37207, United States|Pfizer Investigational Site, Nashville, Tennessee, 37211, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Salt Lake City, Utah, 84112, United States|Pfizer Investigational Site, Walla Walla, Washington, 99362, United States|Pfizer Investigational Site, Brussels, 1000, Belgium|Pfizer Investigational Site, Brussels, 1070, Belgium|Pfizer Investigational Site, Leuven, 3000, Belgium|Pfizer Investigational Site, Vancouver, British Columbia, V5Z 4E6, Canada|Pfizer Investigational Site, Hamilton, Ontario, L8V 5C2, Canada|Pfizer Investigational Site, Chicoutimi, Quebec, G7H 5H6, Canada|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Avignon Cedex 2, 84082, France|Pfizer Investigational Site, Paris Cedex 05, 75248, France|Pfizer Investigational Site, Paris Cedex 13, 75651, France|Pfizer Investigational Site, Dublin 8, Ireland|Pfizer Investigational Site, Galway, Ireland|Pfizer Investigational Site, Bologna, 40139, Italy|Pfizer Investigational Site, Forli', 47100, Italy|Pfizer Investigational Site, Modena, 41100, Italy|Pfizer Investigational Site, Roma, 00144, Italy|Pfizer Investigational Site, Madrid, 28040, Spain|Pfizer Investigational Site, Madrid, 28041, Spain|Pfizer Investigational Site, Stockholm, 118 83, Sweden|Pfizer Investigational Site, Stockholm, 17176, Sweden|Pfizer Investigational Site, Sutton, Surrey, SM2 5PT, United Kingdom|Pfizer Investigational Site, Glasgow, G11 6NT, United Kingdom|Pfizer Investigational Site, London, SE1 9RT, United Kingdom|Pfizer Investigational Site, London, SW3 6JJ, United Kingdom Less <<
NCT00174356 Carcinoma, Non-Small Cell Lung Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, Illinois Pfizer Investigational Site Park Ridge, Illinois, United States, 60068 Pfizer Investigational Site Skokie, Illinois, United States, 60076 United States, Kentucky Pfizer Investigational Site Louisville, Kentucky, United States, 40202 Pfizer Investigational Site Louisville, Kentucky, United States, 40207 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8V 5C2 Less <<
NCT00050830 Lung Neoplasms Phase 2 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.79mL

0.36mL

0.18mL

8.95mL

1.79mL

0.89mL

17.89mL

3.58mL

1.79mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories